{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:15:37Z","timestamp":1794017737107,"version":"4.8.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"\n Importance<\/jats:title>\n Positive health outcomes of a high cardiovascular health (CVH) score have been demonstrated largely with single CVH assessments in midlife, whereas the association of cumulative CVH during young adulthood with premature cardiovascular disease (CVD) and particularly kidney outcomes remains unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine the association of cumulative CVH from 30 to 40 years of age with the risk of CVD and kidney events in midlife.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This population-based cohort study used Korean National Health Insurance health screening and claims data on adults aged 40 years without prior CVD or chronic kidney disease (CKD). Data were analyzed from May 1, 2024, to April 30, 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Ten-year cumulative CVH score, calculated as the area under the CVH score curve from 30 to 40 years of age (range, 0-100 per visit; cumulative range, 0-1000 points\u2009\u00d7\u2009years), based on the American Heart Association\u2019s Life\u2019s Essential 8 construct.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcomes were CVD events (myocardial infarction, ischemic stroke, heart failure, or cardiovascular death) and kidney events (incident CKD, kidney replacement therapy, or kidney-related death) after 40 years of age among participants.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 241\u202f924 adults (78.1% male [n\u2009=\u2009188\u202f871]; all aged 40 years) with 3 or more examination visits (at 30 and 40 years of age and \u22651 visits in between; median number of visits, 8 [IQR, 6-10]), 2748 CVD events and 2085 kidney events occurred over a median follow-up of 9.2 years (IQR, 8.4-10.1). The highest quintile (quintile 5 [Q5]; \u2265735 points\u2009\u00d7\u2009years) of cumulative CVH from 30 to 40 years of age was associated with a very low incidence of CVD (0.05% per year; adjusted hazard ratio [HR], 0.27 [95% CI, 0.22-0.32] vs Q1) and kidney events (0.05% per year; adjusted HR, 0.25 [95% CI, 0.21-0.31] vs Q1) in midlife. Each 100-point\u2009\u00d7\u2009year higher cumulative CVH (eg, 10-point higher CVH score\u2009\u00d7\u200910 years) was associated with a 34% lower hazard of CVD events and a 35% lower hazard of kidney events. The associations were similar by sex and for event subtypes and remained significant after adjustment for CVH score at 40 years of age or the slope of CVH change.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n These findings suggest that a higher cumulative CVH score from 30 to 40 years of age was associated with markedly lower risks of CVD and kidney events in midlife, highlighting the importance of sustained primordial prevention efforts throughout early life.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamacardio.2025.3269","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:00:39Z","timestamp":1759330839000},"page":"1207","source":"Crossref","is-referenced-by-count":5,"title":["Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife"],"prefix":"10.1001","volume":"10","author":[{"given":"Jong Hyun","family":"Jhee","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Hwa","family":"Ha","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Korea"},{"name":"Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasom","family":"Son","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeok-Hee","family":"Lee","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Chang","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hokyou","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"hbr250015r1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s strategic Impact Goal through 2020 and beyond.","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"issue":"8","key":"hbr250015r2","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart Disease and Stroke Statistics: a report of US and global data from the American Heart Association.","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"issue":"12","key":"hbr250015r3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jacc.2023.01.024","article-title":"Association of incident cardiovascular disease with time course and cumulative exposure to multiple risk factors.","volume":"81","author":"Domanski","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hbr250015r4","first-page":"1","article-title":"Quantification and chemical markers of tobacco-exposure.","volume":"70","author":"Prignot","year":"1987","journal-title":"Eur J Respir Dis"},{"issue":"7","key":"hbr250015r5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jamacardio.2025.0630","article-title":"Cumulative Life\u2019s Essential 8 scores and cardiovascular disease risk.","volume":"10","author":"Walker","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"20","key":"hbr250015r6","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association.","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"hbr250015r7","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life\u2019s Essential 8: updating and enhancing the American Heart Association\u2019s construct of cardiovascular health: a presidential advisory from the American Heart Association.","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"hbr250015r8","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2025.03.024","article-title":"Association between the ideal cardiovascular health score and cardiovascular-kidney outcomes in young adults.","author":"Lee","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"hbr250015r9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/CIRCULATIONAHA.121.054212","article-title":"Associations of ideal cardiovascular health and its change during young adulthood with premature cardiovascular events: a nationwide cohort study.","volume":"144","author":"Lee","year":"2021","journal-title":"Circulation"},{"key":"hbr250015r10","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2024001","article-title":"Identification of acute myocardial infarction and stroke events using the National Health Insurance Service database in Korea.","volume":"46","author":"Cho","year":"2024","journal-title":"Epidemiol Health"},{"issue":"24","key":"hbr250015r11","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1001\/jama.2024.4970","article-title":"Accounting for competing risks in clinical research.","volume":"331","author":"Austin","year":"2024","journal-title":"JAMA"},{"issue":"6","key":"hbr250015r12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"9","key":"hbr250015r13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"11","key":"hbr250015r14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1161\/CIRCULATIONAHA.122.060911","article-title":"Status of cardiovascular health in US Adults and children using the American Heart Association\u2019s new \u201cLife\u2019s Essential 8\u201d metrics: prevalence estimates from the National Health and Nutrition Examination Survey (NHANES), 2013 through 2018.","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"hbr250015r15","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1216693","article-title":"Estimation of Life\u2019s Essential 8 score with incomplete data of individual metrics.","volume":"10","author":"Zheng","year":"2023","journal-title":"Front Cardiovasc Med"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2839100\/jamacardiology_jhee_2025_br_250015_1762209242.36097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T16:01:40Z","timestamp":1762963300000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2839100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2025.3269","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]}}}